GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

enGene Holdings ENGN · USD

Health Care · US listing · 🇺🇸 United States

Compare

1.77

+1.14%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Net income

−$117.3m

FY2020FY2025

Free cash flow

−$100.7m

FY2020FY2025

Shareholders' equity

$167.7m

FY2020FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
Gross profit−$509,000−$323,000−$175,000———
Research and development$94.5m$38.3m$16.5m$15.5m$12.5m$10.6m
Operating income−$123.2m−$62.3m−$94.9m−$19.4m−$15.9m−$13.9m
Net income−$117.3m−$55.1m−$99.9m−$24.5m−$23.4m−$15.1m
Diluted earnings per share-2.29-1.22-3.19-1.55-1.48-0.95

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Total assets$221.5m$311.2m$87.0m$132.0m$131.4m—
Cash and short-term investments$193.8m$238.4m$81.6m$314,151$1.1m—
Total liabilities$53.8m$38.6m$14.5m$4.6m$4.1m—
Debt$25.3m$23.6m$9.8m$32.1m$4.1m—
Shareholders' equity$167.7m$272.6m$72.5m$127.4m$127.4m—
Shares outstanding51m45m31m16m16m16m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations−$99.2m−$48.3m−$24.7m−$17.6m−$16.0m−$13.1m
Capital spending−$1.5m−$925,000−$318,000−$153,000−$248,000−$192,000
Free cash flow−$100.7m−$49.2m−$25.1m−$17.7m−$16.2m−$13.3m

Latest quarters

By quarter end

Jul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024
Revenue———————$480,000
Gross profit−$178,000−$180,000−$189,000−$171,000−$130,000−$106,000−$102,000$240,000
Operating income$34.0m$32.0m−$31.2m−$39.5m−$29.9m−$27.1m−$26.6m−$17.5m
Net income$32.5m$30.2m−$29.8m−$37.9m−$29.0m−$25.8m−$24.6m−$15.3m
Diluted earnings per share0.470.43-0.43-0.74-0.57-0.50-0.48-0.34
Cash from operations−$18.0m−$30.0m−$28.0m−$24.0m−$25.0m−$22.0m−$25.0m−$19.0m
Total assets$288.3m$307.5m$337.1m$221.5m$245.6m$266.7m$285.9m$311.2m
Cash and short-term investments$266.3m$258.5m$275.9m$193.8m$202.0m$217.5m$213.9m$238.4m
Debt$27.4m$27.4m$27.2m$25.3m$24.6m$24.0m$23.8m$23.6m
Shareholders' equity$230.3m$255.2m$281.5m$167.7m$200.7m$227.3m$249.9m$272.6m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income85.1%54.8%—
Net income68.6%50.7%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022
Price to earnings-0.8-1.1-0.6-1.4

Share price return

Finished calendar years

2025202420232022
Return38%-21%-27%4%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.